Auragen Inc., Oxford BioSciences Ltd. deal

Oxford and Auragen formed Geniva Inc. to develop genetic vaccines and other biopharmaceuticals for infectious

Read the full 152 word article

How to gain access

Continue reading with a
two-week free trial.